Literature DB >> 14720314

Cannabis use and cerebrovascular disease.

Michael Moussouttas1.   

Abstract

BACKGROUND: Cannabis is the most commonly abused illicit drug and is often considered innocuous. However, cases of acute onset neurologic dysfunction occurring in relation to cannabis use have been described and corresponding cerebral imaging studies have documented focal ischemic changes and vessel abnormalities. REVIEW
SUMMARY: This article reviews all reported cases of presumed cannabis related cerebral ischemic events in the medical literature, as well as pertinent human and animal experimental studies on the cardiovascular and cerebrovascular effects of cannabis.
CONCLUSIONS: Cannabis use seems to have been causally related to several instances of cerebral ischemia and infarction. Proposed etiologic mechanisms have included cerebral vasospasm, cardioembolization, and systemic hypotension with impaired cerebral autoregulation, but most of the available data points to a vasospastic process. The exact relation of cannabis to cerebrovascular disease remains to be determined.

Entities:  

Mesh:

Year:  2004        PMID: 14720314     DOI: 10.1097/01.nrl.0000107493.19282.b0

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  15 in total

Review 1.  [Party and designer drugs : From ecstasy and crystal meth to angel's trumpet].

Authors:  F Erbguth
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-19       Impact factor: 0.840

2.  Recurrent transient ischemic attacks in a cannabis smoker.

Authors:  C Haubrich; R Diehl; M Dönges; J Schiefer; M Loos; C Kosinski
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

Review 3.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 4.  Addictive illegal drugs: structural neuroimaging.

Authors:  S Geibprasert; M Gallucci; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

Review 5.  Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.

Authors:  Vikas Khullar; Ankur Jain; Maryam Sattari
Journal:  J Gen Intern Med       Date:  2014-02-20       Impact factor: 5.128

6.  Identifying risk factors for marijuana use among veterans affairs patients.

Authors:  Marina Goldman; Jesse J Suh; Kevin G Lynch; Regina Szucs; Jennifer Ross; Hu Xie; Charles P O'Brien; David W Oslin
Journal:  J Addict Med       Date:  2010-03       Impact factor: 3.702

7.  Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.

Authors:  T Schultheiss; K Flau; M Kathmann; M Göthert; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-09-30       Impact factor: 3.000

8.  Acute intoxication caused by a synthetic cannabinoid in two adolescents.

Authors:  Travis S Heath; Zachary Burroughs; A Jill Thompson; Frederick W Tecklenburg
Journal:  J Pediatr Pharmacol Ther       Date:  2012-04

9.  Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic.

Authors:  Emily L Gentes; Amie R Schry; Terrell A Hicks; Carolina P Clancy; Claire F Collie; Angela C Kirby; Michelle F Dennis; Michael A Hertzberg; Jean C Beckham; Patrick S Calhoun
Journal:  Psychol Addict Behav       Date:  2016-05

10.  Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard.

Authors:  Katherine Esse; Marco Fossati-Bellani; Angela Traylor; Sheryl Martin-Schild
Journal:  Brain Behav       Date:  2011-09       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.